Although the HER2-positive, luminal A and luminal B subtypes of breast cancer demonstrated lower expression of PLA2R1 mRNA with median fold changes (0.029, 0.232 and 0.158, respectively), none of these differences approached statistical significance. This evidence concerns the gene ERBB2 and breast carcinoma.